Literature DB >> 17242421

Medication adherence in psychopharmacologically treated adults with ADHD.

Steven A Safren1, Petra Duran, Iftah Yovel, Carol A Perlman, Susan Sprich.   

Abstract

OBJECTIVE: One of the potential causes of residual symptoms of ADHD in adults can be difficulties with consistent adherence to medications.
METHOD: This formative study examined self-reported medication adherence in adults with ADHD with clinically significant symptoms despite medication treatment.
RESULTS: Mean adherence for the two-week period prior to the assessment point was 86%, with 18% of the sample reporting less than 80% adherence, and 43% less than 90% adherence. Adherence correlated with ADHD symptoms but not anxiety or depression. Those with less than 80% adherence had higher ADHD severity compared to those whose adherence was at least 80%.
CONCLUSION: These data suggest that self-report of adherence to ADHD medications may be a useful and expedient way of assessing adherence, and that assessment and counseling about adherence may be an important part of treatment. Future research using an objective indicator of adherence is needed to follow up on these findings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242421     DOI: 10.1177/1087054706292165

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  15 in total

1.  Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Authors:  David J Moore; Kaitlin Blackstone; Steven Paul Woods; Ronald J Ellis; J Hampton Atkinson; Robert K Heaton; Igor Grant
Journal:  AIDS Care       Date:  2012-04-24

2.  Behavioral components of impulsivity predict alcohol consumption in adults with ADHD and healthy controls.

Authors:  Jessica Weafer; Richard Milich; Mark T Fillmore
Journal:  Drug Alcohol Depend       Date:  2010-09-22       Impact factor: 4.492

3.  The Transition of Youth with ADHD into the Workforce: Review and Future Directions.

Authors:  Chanelle T Gordon; Gregory A Fabiano
Journal:  Clin Child Fam Psychol Rev       Date:  2019-09

Review 4.  Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults.

Authors:  Christopher Gibbins; Margaret Weiss
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

5.  Simulated driving performance of adults with ADHD: comparisons with alcohol intoxication.

Authors:  Jessica Weafer; Daniel Camarillo; Mark T Fillmore; Richard Milich; Cecile A Marczinski
Journal:  Exp Clin Psychopharmacol       Date:  2008-06       Impact factor: 3.157

6.  Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.

Authors:  Michel Arvidsson; Marja-Liisa Dahl; Olof Beck; Gerd Ackehed; Karin Nordin; Staffan Rosenborg
Journal:  Eur J Clin Pharmacol       Date:  2019-11-30       Impact factor: 2.953

7.  Assessing medication adherence: options to consider.

Authors:  Audrey Lehmann; Parisa Aslani; Rana Ahmed; Jennifer Celio; Aurelie Gauchet; Pierrick Bedouch; Olivier Bugnon; Benoît Allenet; Marie Paule Schneider
Journal:  Int J Clin Pharm       Date:  2013-10-29

8.  Financial Dependence of Young Adults with Childhood ADHD.

Authors:  Amy R Altszuler; Timothy F Page; Elizabeth M Gnagy; Stefany Coxe; Alejandro Arrieta; Brooke S G Molina; William E Pelham
Journal:  J Abnorm Child Psychol       Date:  2016-08

9.  Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial.

Authors:  Mei-Rong Pan; Shi-Yu Zhang; Sun-Wei Qiu; Lu Liu; Hai-Mei Li; Meng-Jie Zhao; Min Dong; Fei-Fei Si; Yu-Feng Wang; Qiu-Jin Qian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-02-22       Impact factor: 5.270

10.  Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial.

Authors:  J J Sandra Kooij; Michael Rösler; Alexandra Philipsen; Sandra Wächter; Joachim Dejonckheere; Annemarie van der Kolk; Michel van Agthoven; Barbara Schäuble
Journal:  BMC Psychiatry       Date:  2013-01-24       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.